BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 27623005)

  • 1. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.
    Florence CS; Zhou C; Luo F; Xu L
    Med Care; 2016 Oct; 54(10):901-6. PubMed ID: 27623005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017.
    Florence C; Luo F; Rice K
    Drug Alcohol Depend; 2021 Jan; 218():108350. PubMed ID: 33121867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review.
    Oderda GM; Lake J; Rüdell K; Roland CL; Masters ET
    J Pain Palliat Care Pharmacother; 2015; 29(4):388-400. PubMed ID: 26654413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of prescription opioid misuse and abuse.
    Strassels SA
    J Manag Care Pharm; 2009 Sep; 15(7):556-62. PubMed ID: 19739878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
    Birnbaum HG; White AG; Reynolds JL; Greenberg PE; Zhang M; Vallow S; Schein JR; Katz NP
    Clin J Pain; 2006 Oct; 22(8):667-76. PubMed ID: 16988561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
    Roland CL; Ye X; Stevens V; Oderda GM
    J Manag Care Spec Pharm; 2019 Jan; 25(1):18-27. PubMed ID: 30589633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use.
    Winkelman TNA; Chang VW; Binswanger IA
    JAMA Netw Open; 2018 Jul; 1(3):e180558. PubMed ID: 30646016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
    Kumar VM; Agboola F; Synnott PG; Segel C; Webb M; Ollendorf DA; Banken R; Chapman RH
    Value Health; 2019 Apr; 22(4):416-422. PubMed ID: 30975392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Societal costs of prescription opioid abuse, dependence, and misuse in the United States.
    Birnbaum HG; White AG; Schiller M; Waldman T; Cleveland JM; Roland CL
    Pain Med; 2011 Apr; 12(4):657-67. PubMed ID: 21392250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction.
    White AG; Birnbaum HG; Rothman DB; Katz N
    Appl Health Econ Health Policy; 2009; 7(1):61-70. PubMed ID: 19558195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Economic Burden of Opioid Abuse: Updated Findings.
    Kirson NY; Scarpati LM; Enloe CJ; Dincer AP; Birnbaum HG; Mayne TJ
    J Manag Care Spec Pharm; 2017 Apr; 23(4):427-445. PubMed ID: 28345440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals.
    Kirson NY; Shei A; Rice JB; Enloe CJ; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Pain Med; 2015 Jul; 16(7):1325-32. PubMed ID: 25929289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017.
    Reinhart M; Scarpati LM; Kirson NY; Patton C; Shak N; Erensen JG
    Appl Health Econ Health Policy; 2018 Oct; 16(5):609-632. PubMed ID: 30027533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic costs of nonmedical use of prescription opioids.
    Hansen RN; Oster G; Edelsberg J; Woody GE; Sullivan SD
    Clin J Pain; 2011; 27(3):194-202. PubMed ID: 21178601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.
    Meyer R; Patel AM; Rattana SK; Quock TP; Mody SH
    Popul Health Manag; 2014 Dec; 17(6):372-87. PubMed ID: 25075734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.
    Landsman-Blumberg PB; Katz N; Gajria K; Coutinho AD; Yeung PP; White R
    J Manag Care Spec Pharm; 2017 Jul; 23(7):718-724. PubMed ID: 28650247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data.
    Saloner B; Chang HY; Krawczyk N; Ferris L; Eisenberg M; Richards T; Lemke K; Schneider KE; Baier M; Weiner JP
    JAMA Psychiatry; 2020 Nov; 77(11):1155-1162. PubMed ID: 32579159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.